ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Session » Rheumatoid Arthritis - Clinical Aspects (ACR): Comorbidities, Treatment Outcomes and Mortality

Meeting: 2014 ACR/ARHP Annual Meeting

Abstract Number: 1362
Impact of Rapid Attainment of Stringent Measures of Efficacy in Rheumatoid Arthritis on Patient-Reported Outcomes
Abstract Number: 1363
Psychosocial Comorbidities Are Independently Associated with Subclinical Atherosclerosis in Rheumatoid Arthritis
Abstract Number: 1364
Accelerated Diastolic Dysfunction in Premenopausal Women with Rheumatoid Arthritis
Abstract Number: 1365
ARE Erosions a Disappearing Feature in Rheumatoid Arthritis (RA)?Joint Damage in Patients with EARLY RA at 10 YEARS after Diagnosis
Abstract Number: 1366
Outcomes of Interstitial Lung Disease Associated with Rheumatoid Arthritis in High Volume Referral Centers
Abstract Number: 1367
Cardiovascular Morbidity and Associated Risk Factors in Spanish Patients with Chronic Inflammatory Rheumatic Diseases Attending Rheumatology Clinics
Abstract Number: 1368
Are Tender Joints Better Than Synovitis to Predict Structural Damage in Rheumatoid Arthritis?
Abstract Number: 1369
Predictors of Deterioration in Subjective Cognition: Results from a Rheumatoid Arthritis (RA) Observational Cohort Study
Abstract Number: 1370
The Association of Body Mass Index (BMI) and Radiographic Progression of Joint Disease in Rheumatoid Arthritis (RA)
Abstract Number: 1371
Impact of Metabolic Syndrome (MetS) on Rheumatoid Arthritis Disease Activity
Abstract Number: 1372
Prevalence of Cardiovascular Disease in US Veterans with Rheumatoid Arthritis and Hepatitis C Infection
Abstract Number: 1373
Physical Function of Patients with RA Varies Importantly Across Countries, and These Differences Are Not Attributed to GDP: Results from Multi-National Study with 17 Countries
Abstract Number: 1374
A Comparison of the Risk for Cardiovascular Event in Patients with Rheumatoid Arthritis Treated with Biologic Disease Modifiers and Patients Treated with Methotrexate Only
Abstract Number: 1375
Educational Level and Not Ethnicity an Important Determinant of Disease Progression in Patients with Rheumatoid Arthritis
Abstract Number: 1376
Angiographic Pattern Among Rheumatoid Arthritis Patients Who Are Hospitalized Due to Acute Coronary Syndrome
Abstract Number: 1377
Anti-Citrullinated Peptide Antibody Titers and the Prevalence of Interstitial Lung Disease in Patients with and without Rheumatoid Arthritis
Abstract Number: 1378
the Impact of Rheumatoid Arthritis Activity and Medications on Pregnancy Outcomes
Abstract Number: 1379
Studies on Ageing and the Severity of Radiographic Joint Damage in Rheumatoid Arthritis
Abstract Number: 1380
Patient Global Impression of Change for Patient Reported Outcomes in Rheumatoid Arthritis: Impact of Comorbidities
Abstract Number: 1381
Subaxial Cervical Spine Involvement in Symptomatic Rheumatoid Arthritis Patients: Comparison with Cervical Spondylosis
Abstract Number: 1382
The Longitudinal Course of Fatigue in Rheumatoid Arthritis – Results from the Norfolk Arthritis Register
Abstract Number: 1383
Disease Characteristics and RA Development in Undifferentiated Arthritis: A 2-Year Follow-up Study of 413 Patients with Arthritis of Less Than 16 Weeks Duration
Abstract Number: 1384
Fibromyalgia and Its Effect on Treatment Response in Early Rheumatoid Arthritis Patients  
Abstract Number: 1385
What Discriminates Best Flares in Rheumatoid Arthritis (RA)? a Subanalysis of the Strass Treatment Tapering in RA Study
Abstract Number: 1386
Disease Flares during 10 Year Follow-up in Patients with Rheumatoid Arthritis Are Associated with Joint Damage Progression and Disability
Abstract Number: 1387
Radiographic Progression Differs Between Trajectory Clusters Defined By DAS28 Scores in Early Rheumatoid Arthritis
Abstract Number: 1388
Prevalence and Predictive Factors of Drug-Free and Sustained Remission in Patients with Early Arthritis
Abstract Number: 1389
Osteophytes Increase the Ambiguity of Clinical Evaluation of Joint Swelling in Rheumatoid Arthritis
Abstract Number: 1390
Heterogeneity in Cardiovascular Risk Factors, Event Rates and RA Disease Characteristics Among Patients with Rheumatoid Arthritis Across 10 Countries – Implications for CV Risk Assessment
Abstract Number: 1391
Weight Loss and Risk of Death in Rheumatoid Arthritis
Abstract Number: 1392
Predictors of Long-Term Changes in Body Mass Index in Rheumatoid Arthritis
Abstract Number: 1393
Periodontal Disease and Its Impact on Structural Joint Damage in a Rheumatoid Arthritis Peruvian Population
Abstract Number: 1394
Low Vitamin D Level Is Not Associated with Increased Risk of Cardiovascular Disease in Rheumatoid Arthritis Patients
Abstract Number: 1395
Disease Activity Is Associated with Insulin Resistance in Early Rheumatoid Arthritis
Abstract Number: 1396
Assessment of Pulmonary Function in Rheumatoid Arthritis Patients Attending Rheumatology Clinics in Nairobi,Kenya
Abstract Number: 1397
Impact of Corticosteroid Use on Remission Sustainability and Infection Rates Among Rheumatoid Arthritis Patients in Remission While on Infliximab: Treatment Implications Based on a Real-World Canadian Population
Abstract Number: 1398
Spontaneous Regression of Methotrexate (MTX)-Related Lymphoproliferative Disorder Correlates with Lymphocyte Restoration after MTX Withdrawal
Abstract Number: 1399
Proteinase K-like Serine Protease PCSK9 Influence on the Dyslipidemia and Endothelial Dysfunction Observed in Rheumatoid Arthritis Patients
Abstract Number: 1400
Risk of Venous Thromboembolic Events in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
Abstract Number: 1401
Higher-Order Neuropsychological Deficits Are Frequent and Occur Early in RA and SLE: The Impact of Basic Processing Abilities on Psychological Well-Being
Abstract Number: 1402
Parameters of Periodontitis Correlate with Anti-Citrullinated Protein Antibodies and P. Gingivalis Antibody Titers in Patients with Early or Chronic Rheumatoid Arthritis
Abstract Number: 1403
Psychosocial Impact of Rheumatoid Arthritis Patients on Their Family Members
Abstract Number: 1404
Presence and Significance of Anti-CCP Antibody in Patients with Interstitial Lung Disease with and without Clinically Apparent Rheumatoid Arthritis
Abstract Number: 1405
Five-Year Changes in Myocardial Structure and Function in Patients with Rheumatoid Arthritis
Abstract Number: 1406
Comorbidity in Rheumatoid Arthritis.  It Is Feasible to Record Concomitant Medical Conditions and Multi-Morbidity in Observational Research Studies. Can This be Extended to Routine Clinical Settings?
Abstract Number: 1407
Low HAQ and Pain Predict Patient Perceived Remission in Rheumatoid Arthritis Patients Receiving MTX or Anti-TNF-Alpha Treatment
Abstract Number: 1408
Inflammatory Biomarkers, Sleep Quantity and Sleep Quality in Rheumatoid Arthritis
Abstract Number: 1409
Pregnancy Outcomes after Exposure to Certolizumab Pegol: Updated Results from Safety Surveillance
Abstract Number: 1410
Low Rates of Cardiovascular Risk Factor Modification Among High-Risk Rheumatoid Arthritis Patients: Barrier to Cardiovascular Prevention Strategies?
Abstract Number: 1411
Psychological Distress over Time in Early Rheumatoid Arthritis: Results from a Longitudinal Study in an Early Arthritis Cohort
Abstract Number: 1412
Sarcopenia and Its Impact on Disability in Rheumatoid Arthritis, a Pilot Study
Abstract Number: 1413
The Prevalence of Renal Impairment in Patients with Rheumatoid Arthritis
Abstract Number: 1414
Investigation of the Association Between Gastroesophageal Reflux Disease and Clinical Factors in Patients with Rheumatoid Arthritis
Abstract Number: 1415
Differential Gender Impact in the Quality of Life of Patients with Rheumatoid Arthritis. Comprehensive Study Including Clinical, Comorbidity and Psicho-Social Variables.
Abstract Number: 1416
Analysis of Cardiac Involvement in Patients with Amyloid a (AA) Amyloidosis Due to Rheumatoidarthritis
Abstract Number: 1417
Red Cell Distribution Width: A Measure for Cardiovascular Risk in Rheumatoid Arthritis Patients?
Abstract Number: 1418
Prevalence of Vitamin D Deficiency in Rheumatoid Arthritis
Abstract Number: 1419
Rituximab Use in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease and Other Connective Tissue Disease-Associated Interstitial Lung Disease: A Single Center Experience
Abstract Number: 1420
Non-Use of Glucocorticoid and Osteoarthritis Absence As Predictors of Clinical Remission in AR
Abstract Number: 1421
Preclinical Interstitial Lung Disease in Early Rheumatoid Arthritis
Abstract Number: 1422
Demographic Differences in Health Related Information Technology Use Among Patients with Rheumatic Diseases
Abstract Number: 1423
Cardiovascular Risk Estimation in Rheumatoid Arthritis: What Is Missing in Traditional Risk Estimators?
Abstract Number: 1424
Bone Erosions in Patients with RA: Exploring the Impact of the Anatomy of Interest on the Relationship Between MRI and X-Ray Erosion Detection
Abstract Number: 1425
Screening Behavior and Prevalence of Hepatitis C Virus in Mexico
Abstract Number: 1426
Periodontal disease and Clinical Activity of Rheumatoid Arthritis Patients
Abstract Number: 1427
Low Prevalence of Sarcopenic Obesity in Rheumatoid Arthritis Patients with Moderate Clinical Activity
Abstract Number: 1428
Comparison of Application of the European Society Cardiology, Adult Treatment Panel III, and ACC/AHA Guidelines for Cardiovascular Disease Prevention in a French Cohort of Rheumatoid Arthritis
Abstract Number: 1429
Systemic Inflammation in Alzheimer’s Disease:  Relevance to Patients with Rheumatoid Arthritis
Abstract Number: 1430
IMPACT of Initiative to Control Cardiovascular Risk Factors in Collaboration with LOCAL Doctors in Patients with Rheumatoid Arthritis
Abstract Number: 1431
Influence of Radiographic Joint Damage in Mortality Risk in a Cohort of Rheumatoid Arthritis Patients: A 20 Years Survival Study
Abstract Number: 1432
Mortality Ratio of Rheumatoid Arthritis Under Biological Treatment
Abstract Number: 1433
Clinical Characterization of Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
Abstract Number: 1434
The Longitudinal Association Between Inflammation and Blood Pressure in Rheumatoid Arthritis
Abstract Number: 1435
Changes in the Types and Prognoses of Infections Complicated in RA Patients during the Last 15 Years, in Japan.
Abstract Number: 1436
Impact of Depression on Clinical and Social Outcomes in Patients with Rheumatoid Arthritis: Comparative Study in Germany and Brazil
Abstract Number: 1437
Cholesterol Efflux Capacity of HDL and Coronary Atherosclerosis in Rheumatoid Arthritis
Abstract Number: 1438
Association Between Chronic Inflammatory Conditions and Anti Cyclic Citrullinated Peptide Antibodies in Patients with Early Rheumatoid Arthritis
Abstract Number: 1439
Miscarriage in Rheumatoid Arthritis – Association with Disease Characteristics and Medication Use
Abstract Number: 1440
Asymptomatic Carotid Plaques in RA Patients Are Associated with Increased HDL Function
Abstract Number: 1441
Accelerated Aging in DMARD and Treatment Naive Early Rheumatoid Arthritis Patients Measured By a Stem Cell Assay Is Associated with Increased LDL and Is Linked to Impaired Cardiopulmonary Function
Abstract Number: 1442
The 2013 ACC/AHA Cardiovascular Risk Prediction Model and Coronary Atherosclerosis in Patients with Rheumatoid Arthritis
Abstract Number: 1443
Increased Occurence of Carotid and Femoral Plaques, but Not Increased Arterial Stiffness of Hypertrophy, in Classical Risk Factor-Free Patients with Rheumatoid Arthritis

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences